CN108815463A - Natural drug, preparation method and application with cancer prevention effect - Google Patents

Natural drug, preparation method and application with cancer prevention effect Download PDF

Info

Publication number
CN108815463A
CN108815463A CN201810882204.0A CN201810882204A CN108815463A CN 108815463 A CN108815463 A CN 108815463A CN 201810882204 A CN201810882204 A CN 201810882204A CN 108815463 A CN108815463 A CN 108815463A
Authority
CN
China
Prior art keywords
cancer
weight
parts
preparation
turmeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810882204.0A
Other languages
Chinese (zh)
Inventor
李军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810882204.0A priority Critical patent/CN108815463A/en
Publication of CN108815463A publication Critical patent/CN108815463A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of natural drug with cancer prevention effect, preparation method and applications.The natural drug with cancer prevention effect is formulated by the raw material of following parts by weight:The turmeric of 30-70 parts by weight, the broccoli of 5-20 parts by weight, the rainbow conk of 10-50 parts by weight, the yeast beta-dextran of 5-20 parts by weight and 5-20 parts by weight pepper.The Cancer-causing mutation that natural drug of the present invention forms by reducing intracorporal carcinogen, hazardous compound is prevented to induce, forms the primary prevention of cancer;Cancer early stage patient tumour inflammation is reduced by immunocytes such as activated lymphocyte, macrophages, improves the clinical symptoms of tumor patient, forms the secondary prevention of cancer;It is acted synergistically by cancer patient and other chemotherapeutics, inhibits drug resistance of tumor, form the tertiary prevention of cancer, the final incidence and the death rate for reducing cancer achievees the purpose that cancer prevention.

Description

Natural drug, preparation method and application with cancer prevention effect
Technical field
The present invention relates to biochemistry field of medicaments, and in particular to natural drug, its preparation with cancer prevention effect Methods and applications.Natural drug of the present invention is formed by reducing intracorporal carcinogen, hazardous compound is prevented to induce Cancer-causing mutation forms the primary prevention of cancer;Cancer early stage is reduced by immunocytes such as activated lymphocyte, macrophages to suffer from Person's tumour inflammation, improves the clinical symptoms of tumor patient, forms the secondary prevention of cancer;Pass through cancer patient and other chemotherapeutics Object synergistic effect, inhibits drug resistance of tumor, forms the tertiary prevention of cancer, and the final incidence and the death rate for reducing cancer reaches To the purpose of cancer prevention.
Background technique
Cancer, also known as malignant tumour are a kind of diseases characterized by undesired cell proliferation.Induce expression of proto-oncogenes Factor mainly has 3 kinds:Energy-ray, chemical substance, virus.Research confirms, contacts and take in the various chemical carcinogenesis in environment Object, such as BaP, aflatoxins, organochlorine phosphorus pesticide and nitrosamine compound are the main reason for various cancers occur. After how effectively realizing that these substances are contactd by mistake by human body, the formation of internal carcinogen not will lead to, be pre- anti-cancer hair Raw the first line of defence.
In general, modern medicine is treated usually based on operation, chemotherapy and radiotherapy after if cancer unfortunately occurs Tumour, since these means also can largely anti-personnel normal cell while killing tumour, it will give people Body bring serious toxic side effect and pain sensation by.Therefore the mitigation for how realizing cancer clinical symptom, prevents the expansion of tumour It is second and the three lines of defence of pre- anti-cancer with transfer.
If certain mode can be taken to reduce or even prevent ever-increasing cancer morbidity, mitigate the pain of cancer sufferer Hardship extends the period and promotes life quality, while avoiding using some high and strong therapeutic agent, undoubtedly to cancer patient It is beneficial.
In recent years, the weight that there is the active constituent of cancer chemoprevention effect to become cancer research for screening from natural plants Want one of direction.
Early stage canceration or in cancer cell forming process, before being inhibited using the lower natural or synthetic chemical substance of toxicity Body compound forms real carcinogenic substance, and prevent its be in contact with intracellular macromolecular such as DNA, RNA or protein and Reaction, until being completely exhausted out external;Or it is pernicious to reduce by each stage that reverse, blocking or delay cancer occur The Critical policies that tumorigenic danger is prevention, inhibits or cancer is reversed to occur.This process, that is, so-called " change of cancer Learn prevention ".
The process that research discovery for many years promotes body itself to eliminate chemical carcinogen occurs that I phase and II can be divided into liver Phase.First after I phase metabolic enzyme such as Cytochrome P450 effect, hydroxyl is introduced in hydrophobic chemical carcinogen;Then in liver Dirty II phase metabolic enzyme such as glutathione transferase (GST), nicotinamide-adenine dinucleotide phosphate (NADP) quinone oxidoreductase (NQO1), it under the action of uridine diphosphate glucuronatetransferase (UGTPGT) etc., is glycosylated again on the hydroxyl generated, It further increases the water solubility of compound and it is promoted to excrete.Therefore, inhibit the activity of I phase metabolic enzyme and improve induction II The activity of phase metabolic enzyme is the committed step of cancer chemoprevention.Find low toxicity, the natural plant extracts of safety become various countries The research emphasis and difficult point of cancer prevention.The antitumoral compounds sulforaphane (SFN) such as extracted from brassicaceous vegetable, it It is the strength inducer of II phase metabolic enzyme, it can GST and NQO1 in rat bladder tissue and external bladder cells in significant inductor Expression (Zhang Y, Munday R, Jobson HE, the et al.Induction of GST and NQO1 in of enzyme cultured bladder cells and in the urinary bladders of rats by an extract of Broccoli (Brassica oleracea itallca) sprouts.J Agric Food Chem, 2006,54 (25): 9370-9376.).In addition, how to adjust cancer starting and develop relevant signaling pathway molecule out of control, to prevent carcinogenic The starting protection DNA of effect is from being mutated, inhibiting tumor cell proliferation, antitumor infiltration and DISTANT METASTASES IN, and realization cancer An important factor for prevention.
Summary of the invention
To solve the above-mentioned problems, the present invention provides a kind of natural drugs with cancer prevention effect, its preparation side Method and application.The natural drug not only itself has good cancer prevention effect, moreover it is possible to be combined reductionization with chemotherapeutics Treat the toxic side effect of drug.The present composition can be used for preparing any one following product:1) prevent and/or treat tumour Drug;2) health care product;3) food;Or 4) nutrient prime replenisher.Tumour mentioned in the present invention includes lung cancer, liver cancer, white Blood disease, breast cancer, cancer of the esophagus, gastric cancer, cervical carcinoma, prostate cancer, the carcinoma of the rectum, Gastric stromal tumors, oophoroma, preferably lung cancer.
The present invention provides a kind of natural drug with cancer prevention effect, by the raw material preparation of following parts by weight At:
The turmeric of 30-70 parts by weight, the broccoli of 5-20 parts by weight, the rainbow conk of 10-50 parts by weight, 5-20 parts by weight ferment The pepper of female beta glucan and 5-20 parts by weight.
Further, the natural drug with cancer prevention effect is formulated by the raw material of following parts by weight:
The turmeric of 50 parts by weight, the broccoli of 30 parts by weight, the rainbow conk of 10 parts by weight, 10 parts by weight yeast beta-dextran With the pepper of 10 parts by weight.
The present invention also provides the preparation methods of the natural drug described in one kind with cancer prevention effect, including following step Suddenly:
Turmeric, broccoli, rainbow conk and pepper are weighed in parts by weight as extracting to obtain ginger respectively after raw material grind Yellow extract, Caulis et Folium Brassicae capitatae, Coriolus Versicolor P.E. and Fructus Piperis extract add after yeast beta-dextran mixing and medicine are added It learns acceptable auxiliary material and is mixed and made into acceptable any dosage form.
Further, the preparation of the Turmeric P.E includes:It takes turmeric to be ground into coarse powder, smashed turmeric 5 is added Three times, 1.5~2 hours every time, add 2~3 times of amount concentration was the ethyl alcohol and heating extraction that~8 times of amount concentration are 80~85% 80%~85% ethyl alcohol soaked extracting solution, stirring stand 24~48 hours, take supernatant, depressurize and add at 65~75 DEG C Hot filtrate is concentrated into saturated solution, stands until precipitate crystal, take crystal dry Turmeric P.E is spare;
The preparation of the Caulis et Folium Brassicae capitatae includes:Selecting broccoli seed, sprout and/or bulb is raw material, by raw material After mechanical crushing, 3-5 times be added after being mechanically pulverized measures water mixing, adds proper amount of acetic acid, pH is adjusted to 5-6, then according to The parts by weight of broccoli raw material and complex enzyme are 100:The complex enzyme is added in 1 ratio, 25-40 DEG C at a temperature of hydrolyze 2- 8 hours, promote glucosinolate in broccoli to be converted into sulforaphen, hydrolyzate is obtained by filtration, the hydrolyzate is inhaled by macropore Attached resin (resin can select AB-8, D101, HP850, HP870 etc.) column absorption, after having adsorbed, respectively with three times column volume The impurity adsorbed in deionized water and 20% ethanol elution resin, then with the work in 80% ethanol elution resin of three times column volume Property ingredient, the eluent finally obtained at 20-40 DEG C by vacuum concentration, be concentrated into relative density 1.1~1.2 (45 DEG C~ 60 DEG C), then be spray-dried and crush, obtain Caulis et Folium Brassicae capitatae;
The preparation of the Coriolus Versicolor P.E. includes:It takes rainbow conk pulverizing medicinal materials at the coarse powder of 80~120 mesh, is added smashed 15~40 times amount water ultrasonic extraction 60~80 minutes, Aqueous extracts obtain filtrate through ultrafiltration membrance filter, add dense after 95% ethyl alcohol Determining alcohol is reduced to up to 80%, precipitates to obtain polysaccharide, is dried in vacuo, obtains Coriolus Versicolor P.E.;
The preparation of the Fructus Piperis extract includes:Pepper is taken to be ground into the coarse powder of 80~120 mesh, it is added smashed 5~ 8 times of amount concentration be 80~85% ethyl alcohol heating extractions three times, 1.5~2 hours every time, combined extract, filtering and standing, filtrate returned Ethyl alcohol is received, relative density 1.1~1.25 (45 DEG C~60 DEG C) is concentrated into, is dried in vacuo to obtain Fructus Piperis extract.
Further, in the preparation of the Caulis et Folium Brassicae capitatae, the complex enzyme includes with weight ratio 1:1 mixed wood Melon protease: cellulase.
Further, acceptable any dosage form is tablet, soft capsule, hard capsule, the capsule and pill, drop of oral preparation Ball, liposome or granule.
Further, the pharmaceutically acceptable auxiliary material include one of bonding agent, filler, lubricant and disintegrating agent or It is several;Wherein the bonding agent includes in syrup, Arabic gum, gel, D-sorbite, xanthan gum and polyvinylpyrrolidone It is one or more of;The filler includes one of lactose, carbohydrate, cornstarch, calcium phosphate, D-sorbite and DEXTROSE ANHYDROUS Or it is several;The lubricant includes one or more of magnesium stearate, talcum powder, polyethylene glycol and silica;It is described to collapse Solving agent includes one or more of potato starch and sodium carboxymethylcellulose.
The present invention also provides a kind of applications in terms of cancer prevention of natural drug with cancer prevention effect.
Further, the cancer includes lung cancer, liver cancer, leukaemia, breast cancer, cancer of the esophagus, gastric cancer, cervical carcinoma, forefront Gland cancer, the carcinoma of the rectum, Gastric stromal tumors or oophoroma.
The features of the present invention:
1, the present invention is filtered out from food source plant has natural anti-cancer, anti-cancer active matter, has carried out scientific compatibility group Cancer chemoprevention natural drug composition made of conjunction has ideal antitumous effect, not will cause internal organs pathologic damage Evil, it is highly-safe.It is metabolized expression of enzymes by the plant compound activation of safety, II phase of induction and plays cancer chemoprotective effect, The Cancer-causing mutation for preventing hazardous compound from inducing, the secretion for increasing body itself by protection enzyme system effectively prevent to induce cancer Injury of the compound to human body, while having stronger inhibiting effect to I phase metablic enzyme of cytochrome P450s, reduce carcinogenic substance Metabolism activation, ultimate carcinogen generate reduction, to cell DNA generate protective effect.With attenuation, inhibit tumor cell proliferation, Antitumor infiltration and DISTANT METASTASES IN effect.
2, the present invention select natural plants compound can the immunocytes such as activated lymphocyte, macrophage, and can antagonism Tumour itself or the decline of caused by chemotherapeutic medicines immune cell function, reduce chemotherapy adverse effect, mitigate tumour inflammation, improve tumour The clinical symptoms of patient.Chemicotherapy curative effect is improved with other chemotherapy drugs in combination applications, inhibits drug resistance of tumor.
3, the present invention selects natural plants compound by the collaboration or superposition between each natural phytochemicals, Effect more stronger than single use under same concentrations is obtained, the usage amount of single compound is also reduced, is mitigated that may be present To the toxicity of host cell.
4, the present invention uses modern plants medicine extractive technique, and ingredient each in prescription is extracted respectively, clean, is refined into standard Extract, the effective component of each ingredient or position are clear, and content is high, have stringent quality standard, the consistency of analysis method So that system easy to control the quality, has pharmacodynamic substances basis and specific pharmacological activity, curative effect is stablized, and administration absorbs the target that can go directly Position.
5, curative effect of the present invention is high, cheap, easy to use simple and direct, and patient compliance is high, can substantially save cancer patient Treatment cost.
Detailed description of the invention
Fig. 1 is curcumin and derivative prevents the action site schematic diagram that chemical method induces cancer.
Specific embodiment
By studying a large amount of natural drugs, filter out clinical be used for a long time confirms effectively with anti-swollen the present invention The cancer chemoprevention natural drug of tumor effect, natural drug of the invention are mentioned by Turmeric P.E, Caulis et Folium Brassicae capitatae, pepper Take object, Coriolus Versicolor P.E. and yeast beta-dextran composition, the effect of each component as follows:
Turmeric is the dry rhizome of zingiberaceous plant turmeric or Radix Curcumae, is removing blood stasis and promoting blood circulation medicine, returns liver, the spleen channel.Turmeric it is main Effective component is curcumin (Curcumin, Cur).Curcumin is a kind of plant polyphenol, shows that curcumin has through pharmacological research The effect of anti-inflammatory, anti-oxidant, anticoagulant, reducing blood lipid, antiatherosclerosis, antitumor, anti-mutation etc..
Curcumin can significantly inhibit the transfer and infiltration of tumour cell.Inside and outside is it is demonstrated experimentally that curcumin can inhibit lung cancer The proliferation of cell.In experiment in vitro, curcumin can promote the table of Nrf2 in kidney epithelia cell in a manner of dosage and Time Dependent It reaches.From the gene expression path of II phase metabolic enzyme it is found that the number of II phase metabolic enzyme can be increased by activation Nrf2/ARE access Amount, to reinforce the ability of body degradation carcinogenic compound.By years of researches, curcumin is induced through Nrf2/ARE access II phase is metabolized expression of enzymes and plays cancer chemoprotective effect.
Further investigations have shown that curcumin has stronger inhibiting effect to I phase metablic enzyme of cytochrome P450s, mainly It is to inhibit P450IA1/IA2, reduces carcinogenic metabolism activation, ultimate carcinogen generates reduction, generates protection to cell DNA and makees With.Animal experiments show that continuously giving Swiss mouse containing 5% turmeric food 5 days, it can obviously inhibit liver P450-bsContain The level of amount and Cytochrome P450.Meanwhile II the activity of phase enzyme GST significantly improve.Mouse curcumin is given by 250mg/kg 15 days, liver GST activity can be made to improve 18 times.Give rat continuously edible food 4 weeks containing turmeric, GST and UDP-glucose The activity of glucuronyl transferase is obvious to be risen.Induction and activation to I phase enzyme can promote carcinogenic removing toxic substances discharge.
Curcumin, can also directly attack of a variety of chemical factors of antagonism to cell DNA other than the activity for influencing metabolic enzyme. The enhancing and its facedown of inhibition, function of detoxification that curcumin is metabolized carcinogenic substance act on, then can make carcinogenic substance-DNA addition The generation of object is reduced.
In test, curcumin and the action site of derivative prevention chemical method induction cancer are as shown in Figure 1.
Turmeric is known as fabulous tumor prevention effect, especially early stage tumour formation.Curcumin and other chemotherapeutics Object use in conjunction helps to improve chemotherapeutic efficacy.Clinically curcumin can be drawn with adriamycin application with substantially reduced adriamycin The heart and Toxicity of Kidney served.
Clinical research report curcumin it is oral up to 12g/ days when, there is no any toxicity to people, therefore curcumin has been used as one It plants less toxic, effective, expense low (most people can be born) anti-tumor drug and is concerned.
(Proceedings of is found from broccoli sprouting by U.S. John-John Hopkins University researcher within 1992 The National Academy of Sciences, USA.1992,89:2399-2403) sulforaphen, also known as sulforaphane (English name is Sulforaphane).Isothiocyanic acid salt compound contained in broccoli can effectively prevent liver cancer, The cancers such as lung cancer, prostate cancer, breast cancer, the carcinoma of the rectum, NIH mice.Sulforaphane is presently found anti-oxidant, anti-cancer, anticancer The most significant isothiocyanic acid salt compound of activity, is that enzyme induction object is effectively protected in one kind, carcinogenic compound can be protected to draw The injury risen.
Sulforaphane is mainly a kind of inducer of II phase enzyme, can prevent many chemical carcinogens inductions DNA damage and Generation (Hintze KJ, Keck AS, the Finley JW.Induction of hepatic thioredoxin of kinds of tumors Reductase activity by sulforaphane, both in Hepa1c1c7 cells and in male Fisher 344 rats[J]. Nutr Biochem 2003 Mar;14(3):173-179).Sulforaphane can completely inhibit I phase enzyme (such as Cytochrome P450), the expression of mouse macrophage COX-2 can be lowered, to inhibit generation (the Heiss E, Herhaus of tumour C, Klimo K, et a1.Nuclear factor KB is a molecular target for sulforaphane- Mediated anti-infannatory mechanisms [J] J BiolChem, 2001,276 (34):32008- 32015).Due to the lipophilic characteristics of sulforaphane, inhibiting the biosynthesis of phosphatide and other lipid materials is also that sulforaphane lures Guided cell growth stops and an important mechanisms of apoptosis.Sulforaphane can offset carcinogenic chemicals confrontation by number of mechanisms The toxic action of gene, thus protect DNA from mutagenic compounds damage (Kuroiwa Y, Nishikawa A, Kitamura Y, et al.Protective0771Journal of Chinese Medicinal Materials effects of benzyl isothiocyanate and sulforaphane but not resveratrol against Initiation of pancreatic carcinogenesis in hamsters [J] .Cancer Lett, 2006,241 (2):275-280.).Sulforaphane can induce apoptosis of tumor cells, cell growth cycle made to stop, inhibiting a variety of chemical carcinogenesis The metabolism activation and inhibition inflammation of object, it is now recognized that sulforaphane is potential tumor therapeutic agent (Wang Shuran, Xia Wei radish Sulfane and tumour [J] disease control magazine.2004,8 (5);452-455).
Rainbow conk is traditional Chinese medicine, belongs to Polyporaceae plant, has effects that strengthen the body resistance to consolidate the constitution, nourishing the essence and strengthening QI.Rainbow conk is extracted Object polysaccharide-peptide is the high score seed glycopeptide polymer extracted from prepared from coriolus versicolor mycelium.Japanese scholars are reported, in prepared from coriolus versicolor mycelium Proteoglycan (abbreviation PSK) has apparent tumor suppression and immunologic enhancement, non-evident effect.(dry original Wu youth, tumor suppression are more Sugar, foreign medical science: traditional Chinese medicine credit volume, 1982,4: 333).Japanese government approved PSK is controlled for clinical tumor within 1997 It treats.
Recent domestic scholar enhances immune function to Coriolus Versicolor P.E. polysaccharide-peptide and anti-tumor activity has been done more In-depth study, polysaccharide-peptide are applied to clinic as biological regulator at present.Polysaccharide-peptide has apparent righting Eliminating evil effect, can enhance the immune function of normal body and tumor animal, can inhibit the life of in vitro culture animal and human cancer cell It is long, the clinical symptoms of tumor patient can be improved, improve Kanofsky score value.
Polysaccharide-peptide is to play antitumor action by enhancing body's immunity, it mainly enhance T lymphocyte, Macrophage and natural killer cells function (in super polysaccharide-peptide Advances in antitumor activity (J) of Liu Yan, Li Rui at Medicine, 2001,23 (10)).Research shows that after malignant tumor patient takes polysaccharide-peptide, T3, T4 lymphocyte subgroup and cytometer Count (the P that is significantly increased<0.01), bone-marrow-derived lymphocyte is without significant changes (P>0.01).Polysaccharide-peptide can increase the function of T lymphocyte Can, and can antagonism tumour itself or caused by chemotherapeutic medicines T lymphocyte function reduction.
Beta glucan is to be distributed widely in fungi, bacterium and the intracorporal large biological molecule of plant, is to construct a variety of biologies carefully The material of cell wall has antitumor, increasing leucocyte, anti-complement activity, antiviral, anticoagulation, activating macrophage, promotes cell The various biologicals activity such as synthesis, the induction NO synthesis of the factor, also show that various lifes during influencing each other between biology Object activity (such as to the stimulation of animal immune system).Yeast cell wall polysaccharide is reported from Brander in 1958 (Zymosan) since having antitumor action, a large amount of immunization experiments prove that beta glucans can not only activate T/B lymphocyte, huge The immunocytes such as phagocyte (M), natural killer cells (NK), moreover it is possible to which complement activation promotes the generation of cell factor, to siberian crabapple System plays various adjustment effects.
Yeast beta-dextran dextran, Glucan are also known as dextran, are a kind of polysaccharide.Yeast β-the Portugal of research at present is poly- The main target of sugared anti-cancer function is exactly the activity and phagocytosis energy that beta glucan reinforces the macrophage being present in cell tissue Power.The ability of macrophage can be enhanced in yeast beta-dextran, can improve macrophages phagocytic capacity and reach several times or more.Usually tool There is the very strong inhibiting rate to mutant, it can further be locked while protecting and enhancing immunocyte fight capability " the residual tumor cell " for determining dormant period, drug resistance and subclinical lesion, carries out targeting antivirus.
Pepper is the nearly mature or ripening fruits of drying of Piperaceae plant pepper, pungent, heat.Return stomach, large intestine channel, there is middle benefit gas to dissipate It is cold, the effect of lower gas, dissolving phlegm.Modern medicine study show pepper main pharmacodynamics ingredient piperine have it is antitumor, resist it is insane Epilepsy, antidepression, it is anti-oxidant, promote drug metabolism the effects of.Piperine can be improved general naphthalene Lip river as bioavilability reinforcing agent The bioavilability in vivo such as that, choline theophyllinate, curcumin.
Curative effect of the present invention is high, cheap, easy to use simple and direct, has no toxic side effect, and patient compliance is high.It is of the present invention The Cancer-causing mutation that natural drug forms by reducing intracorporal carcinogen, hazardous compound is prevented to induce, forms the one of cancer Grade prevention;Cancer early stage patient tumour inflammation is reduced by immunocytes such as activated lymphocyte, macrophages, improves tumour and suffers from The clinical symptoms of person form the secondary prevention of cancer;It is acted synergistically by cancer patient and other chemotherapeutics, inhibits tumour resistance to Pharmacological property forms the tertiary prevention of cancer, and the final incidence and the death rate for reducing cancer achievees the purpose that cancer prevention.
Embodiment:Utilize the case study on implementation of drug of the present invention
Embodiment 1 (capsule)
It takes 50 parts by weight turmerics to be ground into coarse powder, the ethyl alcohol that 8 times of smashed turmeric amount concentration are 85% and heating is added It extracts three times, 1.5 hours every time, adds the ethyl alcohol soaked extracting solution that 2 times of amount concentration are 80%, stirring stands 48 hours, takes Supernatant, depressurizes and heats filtrate at 70 DEG C and be concentrated into saturated solution, stands until precipitate crystal, take crystal dry turmeric Extract is spare;
10 parts by weight broccoli sprouts are taken to crush coarse powder, 4 times of amount water being added after being mechanically pulverized mix, and add appropriate vinegar PH is adjusted to 6 by acid, is 100 then according to the parts by weight of broccoli raw material and complex enzyme:It is (multiple that the complex enzyme is added in 1 ratio Synthase is with weight ratio 1:1 mixed papain: cellulase), 36 DEG C at a temperature of hydrolyze 6.5 hours, promote west blue It spends middle glucosinolate to be converted into sulforaphen, hydrolyzate is obtained by filtration, the hydrolyzate is adsorbed by large pore resin absorption column, After having adsorbed, respectively with the impurity adsorbed in the deionized water of three times column volume and 20% ethanol elution resin, then with three times column Active constituent in 80% ethanol elution resin of volume, the eluent finally obtained is at 40 DEG C by vacuum concentration, concentration It to relative density 1.12 (45 DEG C), then is spray-dried and crushes, obtain Caulis et Folium Brassicae capitatae;
It takes 20 parts by weight rainbow conk pulverizing medicinal materials at the coarse powder of 120 mesh, smashed 30 times of amount water ultrasonic extraction 80 is added and divides Clock, Aqueous extracts obtain filtrate through ultrafiltration membrance filter, are concentrated into determining alcohol up to 80% after adding 95% ethyl alcohol, precipitate to obtain polysaccharide, Vacuum drying, obtains Coriolus Versicolor P.E.;
10 parts by weight peppers are taken to be ground into the coarse powder of 100 mesh, it is that the heating of 85% ethyl alcohol mentions that smashed 8 times of amount concentration, which is added, It takes three times, 1.5 hours every time, combined extract, filtering and standing, filtrate recycling ethanol, is concentrated into relative density 1.25 (55 DEG C), It is dried in vacuo to obtain Fructus Piperis extract.
It extracts according to the method described above and respectively obtains Turmeric P.E, Caulis et Folium Brassicae capitatae, Coriolus Versicolor P.E., Fructus Piperis extract Afterwards, 10 parts of weight of yeast beta-dextran, 1 parts by weight of magnesium stearate, 1 parts by weight of superfine silica gel powder, dextrin is added and fits 3 weight deal tune Whole total amount mixes, is filled into capsule after pellet through sieves are made.
Embodiment 2 (tablet)
It takes 40 parts by weight turmerics to be ground into coarse powder, the ethyl alcohol that 6 times of smashed turmeric amount concentration are 82% and heating is added It extracts three times, 2 hours every time, adds the ethyl alcohol soaked extracting solution that 2 times of amount concentration are 80%, stirring stands 48 hours, takes Supernatant, depressurizes and heats filtrate at 70 DEG C and be concentrated into saturated solution, stands until precipitate crystal, take crystal dry turmeric Extract is spare;
15 parts by weight broccoli sprouts are taken to crush coarse powder, 4 times of amount water being added after being mechanically pulverized mix, and add appropriate vinegar PH is adjusted to 6 by acid, is 100 then according to the parts by weight of broccoli raw material and complex enzyme:It is (multiple that the complex enzyme is added in 1 ratio Synthase is with weight ratio 1:1 mixed papain: cellulase), 36 DEG C at a temperature of hydrolyze 8 hours, promote broccoli Middle glucosinolate is converted into sulforaphen, and hydrolyzate is obtained by filtration, and the hydrolyzate is adsorbed by large pore resin absorption column, is inhaled It is attached it is complete after, respectively with the impurity adsorbed in the deionized water of three times column volume and 20% ethanol elution resin, then with three times cylinder Active constituent in 80% long-pending ethanol elution resin, the eluent finally obtained, by vacuum concentration, are concentrated at 35 DEG C Relative density 1.15 (55 DEG C), then be spray-dried and crush, obtain Caulis et Folium Brassicae capitatae;
It takes 25 parts by weight rainbow conk pulverizing medicinal materials at the coarse powder of 100 mesh, smashed 25 times of amount water ultrasonic extraction 60 is added and divides Clock, Aqueous extracts obtain filtrate through ultrafiltration membrance filter, are concentrated into determining alcohol up to 80% after adding 95% ethyl alcohol, precipitate to obtain polysaccharide, Vacuum drying, obtains Coriolus Versicolor P.E.;
5 parts by weight peppers are taken to be ground into the coarse powder of 100 mesh, it is that the heating of 80% ethyl alcohol mentions that smashed 6 times of amount concentration, which is added, It takes three times, 2 hours every time, combined extract, filtering and standing, filtrate recycling ethanol, is concentrated into relative density 1.20 (60 DEG C), It is dried in vacuo to obtain Fructus Piperis extract.
It extracts according to the method described above and respectively obtains Turmeric P.E, Caulis et Folium Brassicae capitatae, Coriolus Versicolor P.E., Fructus Piperis extract Afterwards, 15 parts of weight of yeast beta-dextran, 10 parts by weight of lactose, 15 parts by weight of cornstarch are added to be uniformly mixed, lubricant is added 3 parts by weight of magnesium stearate are uniformly mixed, and whole grain, then tablet is made in tabletting.
Embodiment 3 (granule)
It takes 70 parts by weight turmerics to be ground into coarse powder, the ethyl alcohol that 8 times of smashed turmeric amount concentration are 80% and heating is added It extracts three times, 2 hours every time, adds the ethyl alcohol soaked extracting solution that 4 times of amount concentration are 80%, stirring stands 48 hours, takes Supernatant, depressurizes and heats filtrate at 75 DEG C and be concentrated into saturated solution, stands until precipitate crystal, take crystal dry turmeric Extract is spare;
10 parts by weight broccoli sprouts are taken to crush coarse powder, 6 times of amount water being added after being mechanically pulverized mix, and add appropriate vinegar PH is adjusted to 5.5 by acid, is 100 then according to the parts by weight of broccoli raw material and complex enzyme:The complex enzyme is added in 1 ratio (complex enzyme is with weight ratio 1:1 mixed papain: cellulase), 40 DEG C at a temperature of hydrolyze 6 hours, promote west blue It spends middle glucosinolate to be converted into sulforaphen, hydrolyzate is obtained by filtration, the hydrolyzate is adsorbed by large pore resin absorption column, After having adsorbed, respectively with the impurity adsorbed in the deionized water of three times column volume and 20% ethanol elution resin, then with three times column Active constituent in 80% ethanol elution resin of volume, the eluent finally obtained is at 40 DEG C by vacuum concentration, concentration It to relative density 1.10 (55 DEG C), then is spray-dried and crushes, obtain Caulis et Folium Brassicae capitatae;
It takes 10 parts by weight rainbow conk pulverizing medicinal materials at the coarse powder of 100 mesh, smashed 35 times of amount water ultrasonic extraction 80 is added and divides Clock, Aqueous extracts obtain filtrate through ultrafiltration membrance filter, are concentrated into determining alcohol up to 80% after adding 95% ethyl alcohol, precipitate to obtain polysaccharide, Vacuum drying, obtains Coriolus Versicolor P.E.;
5 parts by weight peppers are taken to be ground into the coarse powder of 100 mesh, it is that the heating of 80% ethyl alcohol mentions that smashed 6 times of amount concentration, which is added, It takes three times, 2 hours every time, combined extract, filtering and standing, filtrate recycling ethanol, is concentrated into relative density 1.15 (60 DEG C), It is dried in vacuo to obtain Fructus Piperis extract.
It extracts according to the method described above and respectively obtains Turmeric P.E, Caulis et Folium Brassicae capitatae, Coriolus Versicolor P.E., Fructus Piperis extract Afterwards, 5 parts of weight of yeast beta-dextran, 20 parts by weight of lactose, 10 parts by weight of cornstarch are added to be uniformly mixed, whole grain is dry, system At granule.
Carry out the natural chemical composition that the present invention is further explained below by way of experiment and applies cancer chemoprevention Effect.
One, the influence that case study on implementation 1 of the present invention grows mice transplanted tumor
1 experimental method
1 experiment purpose:Determine the influence that case study on implementation 1 of the present invention grows mice transplanted tumor
2 materials and method:
2.1 tested materials and model comparison
Tested material title and source:Case study on implementation 1 of the present invention.
Model comparison:Distilled water
2.2.2 experimental animal
4~6 week old BALB/c mouses, 40,18-22g, female, ties up tonneau China experimental animal skill purchased from Beijing by SPF grades Art Co., Ltd.Conventional base feed was given before on-test to adapt to 5 days~7 days.
2.2.3 feeding environment
It raises in barrier environment, temperature is 26~28 DEG C (78~820F), relative humidity 40~60%.
2.2.4 tumor inoculation, grouping and administration
Every animal inoculates lung cancer A549 cell 5*106It is a, respectively control group (give same amount physiological saline), it is high, In, low dose group oral administration (200,100,50mg/kg) successive administration observation administration after changes of weight and the time-to-live.Respectively Group continuous gavage be administered 30 days, 1 times/day, observation administration when and 30 days in animal toxic reaction and death condition, after 30 days take off Neck puts to death mouse, and dissection tumour, weighing simultaneously calculate tumour inhibiting rate and carry out statistical test.Experimental result difference is as shown in table 1, In the 2nd, 3,4 group of tumour inhibiting rate be the knurl weight of each group and the ratio of the 1st group of knurl weight respectively.
3 experimental results
Table 1 is as can be seen that high, medium and low dosage can significantly extend the life (p of mice with tumor<0.01), especially with high agent It measures more significant.
1 native chemical of table prevents influence of the composition to Transplantable Murine A549 lung cancer growth
Note:Compared with model group, * * * P < 0.001
Two, using 153 cancer patients of drug therapy of the present invention, and certain curative effect is obtained.
1 data and method
1.1 general information
Patient 153 are taken, wherein male patient is 103, female patient is 50, patient age 35~81 years old, average year Age is 63.28 years old, and the course of disease is 1~3 year.It takes own control to test, that is, chooses and be diagnosed as cancer, controlled by chemicotherapy intervention After treatment or be reluctant to carry out chemicotherapy or can not the patient of operative treatment (being to abandon treating) controlled using drug of the present invention It treats.
1.2 treatment method
Oral case study on implementation 1 of the present invention 5 tablets each time, or is followed the doctor's advice 3 times a day.Blood routine, liver are checked at medication 3 months Kidney function, abdominal CT evaluate curative effect.Responder continues to take, and related content was checked at 6 months, evaluates curative effect.Continue later The person of taking drugs observes life cycle.
1.3 criterion of therapeutical effect
Reference WHO curative effect determinate standard,
Complete incidence graph (CR):Tumor focus fully absorbs;
Alleviate (PR) in part:Tumor focus constantly reduces, but reduces volume and be greater than 50%;
Stablize (SD):Tumor focus constantly reduces, but reduces volume less than 50%;
It is in progress (PD):Tumor focus, which is presented, constantly expands trend, and volume expands 25% or more.
Objective efficient=(alleviating complete incidence graph+part)/evaluable case load × 100% of patient's treatment,
Patient disease control rate=(complete incidence graph+part alleviation+minor responses)/evaluable case load × 100%.
Life cycle index 3 months (people), 6 months (people), 1 year (people), 2 years (people), 3 years (people).
2 results
2.1 clinical efficacy
It treats in 153 patients, complete incidence graph patient is 42, and part reduction of patient is 62, and minor responses patient is 10, refractory patient 39.Objective effective percentage is 81.04%, disease control rate 74.50%.
3 months 8 people of life cycle index, 6 months 28 people, 1 year 65 people, 2 years 34 people, 3 years 18 people.
It is above-mentioned statistics indicate that, the objective efficient and disease control rate of drug therapy of the present invention is higher.
Typical case is only chosen below to be introduced.
Case 1:Mr. Lin, male, 45 years old, cirrhosis merge liver cancer;2014 are after diagnosing cirrhosis merging liver cancer, 2015 The beginning of the year takes orally case study on implementation 1 of the present invention, and daily 14, liver function recovery is normal after half a year, white blood cell from 1084 restore to Normally, blood platelet, albumin restore normal, adhere to medication 3 years, are repeatedly checked tumour and do not find to spread, CT examination in 2017 It was found that reducing 40% tumor focus.
Case 2:Week, certain was blue, female, 73 years old, lung cancer;Lung cancer is diagnosed as through tumour hospital of Peking University within 2014.Do not carry out into The treatment of one step, takes case study on implementation 1 of the present invention, and after taking 3 months according to 3-4-3 methods daily, dyspnea symptom disappears, Cooperation takes Iressa (Gefitinib piece) so far after half a year, and pulmonary lesions disappear.
Case 3:Hao China, female, 82 years old, advanced lung cancer are diagnosed as adenocarcinoma of lung through tumour hospital of Hebei province in November, 2013, 3.5 centimeters of tumor focus, suggest carrying out chemotherapy 1 month through doctor, but patient's age is greatly (being 82 years old at that time), abandoning It treats.It is changed within 2 months 2014 take case study on implementation 2 of the present invention, after taking the present invention 5 months, knurl is reduced into 2.5 centimeters;Together December in year, knurl was reduced into 1.4 centimeters.So far ultrasound diagnosis also has no nascent tumor there is no transfer.
Case 4:Mr. Wang friend, male, 59 years old, later period of hepatocarcinoma, clinical diagnosis in 2014 are later period of hepatocarcinoma, concurrently reveal now double lungs Transfer.Patient is implementing chemical PTCA or and STENTS, takes the present invention always since hospital does not have other suitable treatment methods Case study on implementation 1.Daily 12, after taking 3 course for the treatment of (6 months), liver knurl reduces 50% (about 0.8 centimeter);Double Lung metastases Left tuberculosis stove is eliminated in lesion.
Case 5:Lee ancestral, male, 38 years old, low differentiation adenocarcinoma of lung;Clinical diagnosis in 2016 is low differentiation adenocarcinoma of lung, takes this Invention case study on implementation 1, main suit feels good, and the common side effect of chemotherapy is unobvious, and 6 kilograms of weight gain, pulmonary lesions do not go out Now further development diffusion.
Case 6:Poplar, male, 70 years old, 1 phase of prostate cancer;In June, 2014 is 1 phase of prostate cancer through clinical definite, PSA11.69, prostate have mass tubercle, hard, and size is about 34x36x28mm.Take case study on implementation 2 of the present invention, daily 9 Grain, patient's state of an illness does not occur further to deteriorate after taking 1 year, and inspection has no residual metastasis of cancer, and adenoncus object product in forefront is reduced into 19x28x28mm.Patient main suit's spirit improves, and pain disappears.
The foregoing is merely presently preferred embodiments of the present invention, is not intended to limit the invention, it is all in spirit of the invention and Within principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.

Claims (9)

1. a kind of natural drug with cancer prevention effect, which is characterized in that be formulated by the raw material of following parts by weight:
The turmeric of 30-70 parts by weight, the broccoli of 5-20 parts by weight, the rainbow conk of 10-50 parts by weight, 5-20 parts by weight yeast β- The pepper of glucan and 5-20 parts by weight.
2. the natural drug according to claim 1 with cancer prevention effect, which is characterized in that by following parts by weight Raw material be formulated:
The turmeric of 50 parts by weight, the broccoli of 30 parts by weight, the rainbow conk of 10 parts by weight, the yeast beta-dextran of 10 parts by weight and 10 The pepper of parts by weight.
3. a kind of preparation method of the natural drug according to claim 1 or 2 with cancer prevention effect, feature exist In including the following steps:
Turmeric, broccoli, rainbow conk and pepper are weighed in parts by weight as extracting to obtain turmeric respectively after raw material grind to mention Object, Caulis et Folium Brassicae capitatae, Coriolus Versicolor P.E. and Fructus Piperis extract are taken, adding after yeast beta-dextran mixing and pharmacy is added can The auxiliary material of receiving is mixed and made into acceptable any dosage form.
4. the preparation method of the natural drug according to claim 3 with cancer prevention effect, which is characterized in that
The preparation of the Turmeric P.E includes:Turmeric is taken to be ground into coarse powder, 5~8 times of amount concentration of smashed turmeric, which are added, is Three times, 1.5~2 hours every time, add 2~3 times of amount concentration was 80%~85% to 80~85% ethyl alcohol and heating extraction Ethyl alcohol soaked extracting solution, stirring stand 24~48 hours, take supernatant, depressurize and heating filtrate is concentrated at 65~75 DEG C Saturated solution is stood until precipitate crystal, take crystal dry Turmeric P.E is spare;
The preparation of the Caulis et Folium Brassicae capitatae includes:Selecting broccoli seed, sprout and/or bulb is raw material, by raw material machinery After crushing, 3-5 times be added after being mechanically pulverized measures water mixing, adds proper amount of acetic acid, pH is adjusted to 5-6, then according to western blue The parts by weight of flower raw material and complex enzyme are 100:The complex enzyme is added in 1 ratio, small in 25-40 DEG C of at a temperature of hydrolysis 2-8 When, promote glucosinolate in broccoli to be converted into sulforaphen, hydrolyzate is obtained by filtration, the hydrolyzate is passed through into macroporous absorption Resin column absorption, after having adsorbed, respectively with the impurity adsorbed in the deionized water of three times column volume and 20% ethanol elution resin, Again with the active constituent in 80% ethanol elution resin of three times column volume, the eluent finally obtained passes through at 20-40 DEG C Vacuum concentration, is concentrated into relative density 1.1~1.2 (45 DEG C~60 DEG C), then be spray-dried and crush, obtains Caulis et Folium Brassicae capitatae;
The preparation of the Coriolus Versicolor P.E. includes:Take rainbow conk pulverizing medicinal materials at the coarse powder of 80~120 mesh, it is added smashed 15~ 40 times amount water ultrasonic extraction 60~80 minutes, Aqueous extracts obtain filtrate through ultrafiltration membrance filter, are concentrated into after adding 95% ethyl alcohol Determining alcohol precipitates to obtain polysaccharide up to 80%, and vacuum drying obtains Coriolus Versicolor P.E.;
The preparation of the Fructus Piperis extract includes:It takes pepper to be ground into the coarse powder of 80~120 mesh, smashed 5~8 times of amounts is added Concentration be 80~85% ethyl alcohol heating extractions three times, 1.5~2 hours every time, combined extract, filtering and standing, filtrate recycle second Alcohol is concentrated into relative density 1.1~1.25 (45 DEG C~60 DEG C), is dried in vacuo to obtain Fructus Piperis extract.
5. the preparation method of the natural drug according to claim 1 with cancer prevention effect, which is characterized in that in institute It states in the preparation of Caulis et Folium Brassicae capitatae, the complex enzyme includes with weight ratio 1:1 mixed papain: cellulase.
6. the preparation method of the natural drug according to claim 1 with cancer prevention effect, which is characterized in that described Acceptable any dosage form is tablet, soft capsule, hard capsule, capsule and pill, dripping pill, liposome or the granule of oral preparation.
7. the preparation method of the natural drug according to claim 3 with cancer prevention effect, which is characterized in that described Pharmaceutically acceptable auxiliary material includes one or more of bonding agent, filler, lubricant and disintegrating agent;The wherein bonding agent packet Include one or more of syrup, Arabic gum, gel, D-sorbite, xanthan gum and polyvinylpyrrolidone;The filler packet Include one or more of lactose, carbohydrate, cornstarch, calcium phosphate, D-sorbite and DEXTROSE ANHYDROUS;The lubricant includes One or more of magnesium stearate, talcum powder, polyethylene glycol and silica;The disintegrating agent includes potato starch and carboxylic One or more of sodium carboxymethylcellulose pyce.
8. the application in terms of cancer prevention of the natural drug according to claim 1 or 2 with cancer prevention effect.
9. application according to claim 8, which is characterized in that the cancer include lung cancer, liver cancer, leukaemia, breast cancer, Cancer of the esophagus, gastric cancer, cervical carcinoma, prostate cancer, the carcinoma of the rectum, Gastric stromal tumors or oophoroma.
CN201810882204.0A 2018-08-06 2018-08-06 Natural drug, preparation method and application with cancer prevention effect Pending CN108815463A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810882204.0A CN108815463A (en) 2018-08-06 2018-08-06 Natural drug, preparation method and application with cancer prevention effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810882204.0A CN108815463A (en) 2018-08-06 2018-08-06 Natural drug, preparation method and application with cancer prevention effect

Publications (1)

Publication Number Publication Date
CN108815463A true CN108815463A (en) 2018-11-16

Family

ID=64153574

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810882204.0A Pending CN108815463A (en) 2018-08-06 2018-08-06 Natural drug, preparation method and application with cancer prevention effect

Country Status (1)

Country Link
CN (1) CN108815463A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109875011A (en) * 2019-04-04 2019-06-14 西南医科大学 A kind of natural anti-cancer food
CN113575950A (en) * 2021-08-06 2021-11-02 徐文红 A nutritional product with adjuvant rehabilitation effect for radiotherapy and chemotherapy of cancer patients

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104922181A (en) * 2014-12-09 2015-09-23 林强 Preparation composition containing broccoli extract with effects of improving immunity and suppressing tumors and preparation method of preparation composition
CN106798892A (en) * 2017-03-09 2017-06-06 北京康蒂尼药业有限公司 A kind of chemotherapy combined antitumor Chinese and its application with Synergy and attenuation effect

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104922181A (en) * 2014-12-09 2015-09-23 林强 Preparation composition containing broccoli extract with effects of improving immunity and suppressing tumors and preparation method of preparation composition
CN106798892A (en) * 2017-03-09 2017-06-06 北京康蒂尼药业有限公司 A kind of chemotherapy combined antitumor Chinese and its application with Synergy and attenuation effect

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘红芝等: "酵母β-葡聚糖的功能活性及其分离提取研究进展", 《食品科学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109875011A (en) * 2019-04-04 2019-06-14 西南医科大学 A kind of natural anti-cancer food
CN113575950A (en) * 2021-08-06 2021-11-02 徐文红 A nutritional product with adjuvant rehabilitation effect for radiotherapy and chemotherapy of cancer patients

Similar Documents

Publication Publication Date Title
CN102091315B (en) Ginger and dark plum fruit composition and preparation method thereof, and application of ginger and dark plum fruit composition in preparation of attenuation and synergy medicaments for radiotherapy and chemotherapy of cancers
CN102166335A (en) Ginger and long pepper composition as well as preparation method and application thereof in preparation of toxicity reducing and efficacy enhancing medicament in radiotherapy and chemotherapy of cancer
CN101181529B (en) Chinese medicine composition for curing tumor and preparation method thereof
CN102861284B (en) Traditional Chinese medicine compound preparation for treating non-small cell lung cancer and preparation method thereof
CN100490789C (en) Enteric coated Chinese medicinal capsule for treating cancer and preparation method thereof
CN104491740B (en) A kind of Chinese medicine composition for treating liver cancer and preparation method thereof
CN108524814A (en) A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose
CN102008650B (en) Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof
CN108815463A (en) Natural drug, preparation method and application with cancer prevention effect
CN107468747A (en) A kind of ginseng composition for being advantageous to anticancer, anti-cancer and preparation method thereof
CN102688317B (en) Traditional Chinese medicine for treating liver cancer
CN105596994A (en) Medicine for treating lung cancer cell proliferation
CN105664140A (en) Glycopeptide composition as well as preparation method and application thereof
CN102631409B (en) Health-care medicine formula with functions of enhancing immunity, alleviating physical fatigue and resisting tumor
CN104189782A (en) Anti-tumor medicament composition
CN108186794A (en) A kind of Chinese medicine composition for treating malignant tumour and its preparation method and application
CN102225182B (en) Traditional Chinese preparation capable of inhibiting tumor and enhancing immunity and preparation method thereof
CN109731019B (en) A composition with chemotherapy synergistic effect comprises components, preparation and application
CN107177510A (en) A kind of fontanesia leaf shelf fungus and its purposes in medicine is prepared
CN112022896A (en) Anti-tumor traditional Chinese medicine compound soft capsule preparation and preparation method and application thereof
CN111729056A (en) Anticancer medicine composition and its prepn
CN113952435B (en) Traditional Chinese medicine composition for adjuvant treatment of liver cancer and preparation method thereof
CN103830262A (en) Auxiliary drug used for treating cancer, and applications thereof
CN105943579A (en) Pharmaceutical composition for treating gastric cancer and preparation method of pharmaceutical composition
CN102133383B (en) Ginger and fingered citron composition, preparation method thereof and application of ginger and fingered citron composition in preparation of attenuated synergistic medicaments in cancer radiotherapy and chemotherapy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181116

RJ01 Rejection of invention patent application after publication